glp 1 and glp Understanding GLP-1 receptor agonists their impact on drug discovery What's the difference between the

The CHMP adopted a new pharmaceutical form associated with a new route of administration, tablets for oral use, in four new strengths (1.5 mg, 4 mg, 9 mg and 25 mg)

Shiraki A, et al

While there is no evidence of thermogenic supplements during GLP-1RA treatment, the mechanism warrants further exploration, especially post-GLP-1RA treatment (See Table 1 for specific dosing protocols)

Practice Pearl(s) The dosing regimen of glucagon-like peptide-1 (GLP-1) agonists is characterized by careful initiation and titration to ensure optimal glycemic control while minimizing potential adverse effects

Having said that, I would say a good deal of primary care clinicians are not aware enough about these medications

Gen X users care most about effectiveness (46%), while Gen Z puts affordability first (37%)